Stock Market
Cancer company receives delisting notice; SEC investigation underway
Published in Cancer Weekly, September 23rd, 2003
The delisting notice was received as a result of the company's failure to file its quarterly report on Form 10-Q for the period ended June 30, 2003, as required by NASDAQ Marketplace Rule 4310(c)(14). This delay arises out of the previous announcement of possible accounting irregularities involving the company's accounts receivable and discrepancies relating to the amounts capitalized to date on the company's GeneBank asset.
The company intends to consider its options with respect to the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-09-23)
More Articles from Cancer Weekly
- Cancer Vaccine
Peptide-based vaccine effective against myelodysplastic syndrome - Metastasis
Cancer biologists and a cardiologist take a new look at aggressive tumors - Antitumor Therapy
TRAIL is an inducer of tissue injury in humans - Breast Cancer
Computer analysis of shadows on breast ultrasound improves lesion detection - Breast Cancer
Different pattern of metastatic spread observed in BRCA1 and BRCA2 carriers - Cancer Pathogenesis
Transcription factor Egr-1 is a foundation for angiogenesis during tumor growth - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
